Steve Platt Email & Phone Number

New York, Ny, Us

Cambridge, Ma, Us

Basel, Baselstadt, Ch

Business advisor for the commercial organization within the US Oncology Business Unit. Key functional member of the franchise leadership team working closely with the franchise head, field leadership and brand teams to drive commercial success. P&L responsibility for ~$3B in sales including launch and mature products. Support business partners to meet sales and profitability goals, provide investment analysis for decision making and identify risk and opportunities to influence resource allocation. Responsible for all financial planning processes including annual budget, latest estimates and multi-year strategic planning for all commercial P&L lines. Served as Finance lead partner for 10+ product launch teams within Oncology.• Drove a cultural mindset change within Finance by actively facilitating cross-franchise collaboration through the establishment of joint process improvement initiatives benefiting the overall business unit.• Led the commercial franchise in executing the transition to AI/ML driven automated forecasting thereby significantly reducing manual effort involved in legacy patient model driven processes.• Performed valuation analyses to determine feasibility of purchasing competitive compounds and to evaluate potential licensing and partnership deals with peer pharma companies.• Led the Finance activities for franchise restructuring exercises in the commercial organization.

Basel, Baselstadt, Ch

Business advisor for the Lung, Melanoma & NET franchise within the US Oncology Business Unit. Key functional member of the franchise leadership team working closely with the franchise head, field leadership and brand teams to drive commercial success. P&L responsibility for ~$1.5B in sales including launch and mature products. Support business partners to meet sales and profitability goals, provide investment analysis for decision making and identify risk and opportunities to influence resource allocation. Responsible for all financial planning processes including annual budget, latest estimates and multi-year strategic planning for all commercial P&L lines.

Basel, Baselstadt, Ch

Basel, Baselstadt, Ch

Business advisor for the Clinical Development and Medical Affairs (CDMA) organization within the US Oncology Business Unit. Lead for overall budget planning, consolidation and trade-off decisions for over $105M in the areas of Phase IV clinical studies, health economics and outcomes research, scientific communications, medical grants/sponsorships and drug supply. Responsible for integrating a team of CDMA planning analysts into the Finance organization while developing their skills as financial stewards for the business. • Managed a $105M clinical trials budget to within 1% variance. This represented a significant improvement over the trend from previous years. • Implemented a process to provide early warning of rolling forecast variances which assisted the business in taking necessary measures to minimize impact and mitigate risk.• Fully streamlined all management reporting for CDMA external/internal expenses and headcount to provide focused insight on key metrics.

Switzerland 🇨🇭 , Ch

Business advisor for the Chief Medical Officer while leading a team of seasoned finance professionals to proactively challenge the business decisions of nine franchise clinical teams to ensure the most value added result is achieved. Responsible for overall budget planning, consolidation and resource decisions for over $150M in the areas of Phase IV clinical studies, medical data analysis, publications and thought leader management. • Successfully implemented an initiative to clearly outline the financial responsibilities of all levels in the medical organization. Led the efforts to establish documentation and train personnel on budget, accrual and reporting processes and effective budget management techniques. Efforts were recognized by senior management as a key component to the successful 2008 performance.• Served as Medical Affairs Controller for the Roche-Genentech Integration.

Switzerland 🇨🇭 , Ch

Business advisor for the Heads of Primary Care and Specialty Care Commercial Operations supporting an annual expense budget of over 1300 headcount and $700M. Provided a team of nine senior financial professionals with the coaching and guidance necessary to allow them to function as key marketing brand team members while maintaining their role as the financial conscience of the organization. • Managed the U.S. co-promotion agreement for a $600M compound in the area of Osteoporosis. • Managed all of the financial aspects of the 10 Year Strategic Business Plan. Developed long range profitability scenarios culminating in a full business economics analysis of the U.S. operations.• Served as the Finance representative in the pandemic planning efforts for all Roche U.S. sites.

Switzerland 🇨🇭 , Ch

Business advisor for Primary Care Marketing and Sales. Completed financial analysis of marketing program proposals, product launch scenarios and business development ventures. Reviewed and analyzed operating results and accruals. Prepared annual expense budgets and quarterly latest estimate projections in excess of $200M. Managed the harmonization of Primary Care and Specialty Care Finance after a planned consolidation. Provided analysis on third party licensing and co-promotion deals with major pharma partners focused on enhancing the profitability of the mature products line.

B.S., Industrial Engineering

Mba